Non Cystic Fibrosis Bronchiectasis — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for non cystic fibrosis bronchiectasis. 56 active patents protecting 1 drugs from 1+ originators. First major cliff: 2035. Daily refresh.

1
Approved drugs
56
Active US patents
68/100
Avg vulnerability
—
Annual revenue covered

Originators in Non Cystic Fibrosis Bronchiectasis

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Insmed Inc 56 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating non cystic fibrosis bronchiectasis. Each bar = one year. Y-axis scaled to peak year (24 patents).

24
35
2
39
2
40

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Brinsupri
BRENSOCATIB
 Insmed Inc 56 68 — 2035-01-21

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11655222 Brinsupri method of use 75 2035-01-21
11655224 Brinsupri method of use 75 2035-01-21
11655221 Brinsupri method of use 75 2035-01-21
9815805 Brinsupri method of use 75 2035-01-21
11814359 Brinsupri method of use 75 2035-01-21
11773069 Brinsupri method of use 75 2035-01-21
11655223 Brinsupri method of use 75 2035-01-21
10287258 Brinsupri method of use 75 2035-01-21
11655223 Brinsupri method of use 75 2035-01-21
11655224 Brinsupri method of use 75 2035-01-21

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
9522894 Brinsupri composition of matter 17 2035-03-12
9522894 Brinsupri composition of matter 17 2035-03-12
12059424 Brinsupri formulation 55 2040-02-21
12059424 Brinsupri formulation 55 2040-02-21
12201638 Brinsupri formulation 55 2039-03-01
12201638 Brinsupri formulation 55 2039-03-01
11773069 Brinsupri method of use 75 2035-01-21
11814359 Brinsupri method of use 75 2035-01-21
11655224 Brinsupri method of use 75 2035-01-21
11655223 Brinsupri method of use 75 2035-01-21

Related